Brief: Fennec Pharma Reports FDA Approval Of Pedmark
21/09/2022 12:29
Sept 21 (Reuters) - Fennec Pharmaceuticals Inc FENC.O :
* FENNEC PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF PEDMARK®
(SODIUM THIOSULFATE INJECTION)
Source text for Eikon: ID:nGNX2bmZ6Q
Further company coverage: FENC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fennec Pharmaceuticals
See all newsFennec Pharmaceuticals Inc. reports results for the quarter ended June 30 - Earnings Summary
Fennec Pharmaceuticals Q2 sales rise on PEDMARK demand
Fennec Pharmaceuticals Inc. expected to post earnings of 1 cent a share - Earnings Preview
Fennec Pharmaceuticals Q1 sales rise 73% on PEDMARK demand
U.S. STOCKS ON THE MOVE-UnitedHealth, Intel, Apple